Free Trial

CVRx (CVRX) Competitors

CVRx logo
$12.35 -0.61 (-4.71%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$12.56 +0.21 (+1.67%)
As of 07:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVRX vs. CDRE, LQDA, INMD, BLFS, RXST, AORT, MDXG, PLSE, FNA, and ESTA

Should you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Cadre (CDRE), Liquidia (LQDA), InMode (INMD), BioLife Solutions (BLFS), RxSight (RXST), Artivion (AORT), MiMedx Group (MDXG), Pulse Biosciences (PLSE), Paragon 28 (FNA), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

CVRx vs.

CVRx (NASDAQ:CVRX) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Cadre has a net margin of 6.34% compared to CVRx's net margin of -116.91%. Cadre's return on equity of 12.88% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-116.91% -93.06% -51.78%
Cadre 6.34%12.88%6.06%

Cadre has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$51.29M6.27-$59.97M-$2.69-4.59
Cadre$516.16M2.55$38.64M$0.8339.06

CVRx has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

CVRx presently has a consensus target price of $17.83, suggesting a potential upside of 44.40%. Cadre has a consensus target price of $39.67, suggesting a potential upside of 22.35%. Given CVRx's stronger consensus rating and higher probable upside, analysts plainly believe CVRx is more favorable than Cadre.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Cadre
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

75.3% of CVRx shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 18.9% of CVRx shares are owned by insiders. Comparatively, 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

CVRx received 17 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 73.33% of users gave CVRx an outperform vote while only 55.17% of users gave Cadre an outperform vote.

CompanyUnderperformOutperform
CVRxOutperform Votes
33
73.33%
Underperform Votes
12
26.67%
CadreOutperform Votes
16
55.17%
Underperform Votes
13
44.83%

In the previous week, CVRx had 1 more articles in the media than Cadre. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Cadre. CVRx's average media sentiment score of 0.97 beat Cadre's score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cadre
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

CVRx beats Cadre on 10 of the 18 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVRX vs. The Competition

MetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$321.55M$4.58B$5.81B$8.43B
Dividend YieldN/A36.92%4.76%3.97%
P/E Ratio-4.5930.3924.9319.24
Price / Sales6.2750.34375.35110.20
Price / CashN/A51.0838.0534.58
Price / Book4.526.267.374.28
Net Income-$59.97M$67.64M$3.18B$247.04M
7 Day Performance-6.58%-5.18%-2.92%-3.26%
1 Month Performance-24.00%-9.68%-6.83%-6.57%
1 Year Performance-38.25%10.60%12.61%4.01%

CVRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVRX
CVRx
2.366 of 5 stars
$12.35
-4.7%
$17.83
+44.4%
-40.6%$321.55M$51.29M-4.59160
CDRE
Cadre
2.3169 of 5 stars
$33.34
-0.7%
$39.67
+19.0%
-9.3%$1.35B$482.53M40.172,435Upcoming Earnings
LQDA
Liquidia
2.9688 of 5 stars
$15.89
-1.4%
$25.38
+59.7%
+2.4%$1.34B$15.61M-9.7550
INMD
InMode
2.0046 of 5 stars
$19.12
+1.2%
$22.25
+16.4%
-17.6%$1.33B$394.82M8.14480Positive News
BLFS
BioLife Solutions
1.4845 of 5 stars
$25.72
-3.6%
$29.43
+14.4%
+36.4%$1.19B$146.96M-24.26440Earnings Report
News Coverage
Positive News
RXST
RxSight
3.5368 of 5 stars
$29.29
-1.0%
$58.13
+98.4%
-51.7%$1.18B$89.08M-35.29220Earnings Report
AORT
Artivion
1.8341 of 5 stars
$27.90
-1.3%
$31.80
+14.0%
+32.2%$1.17B$354M-1,394.901,500High Trading Volume
MDXG
MiMedx Group
3.2735 of 5 stars
$7.95
-0.4%
$12.00
+50.9%
-3.8%$1.17B$321.48M14.45870Earnings Report
Analyst Revision
PLSE
Pulse Biosciences
1.4094 of 5 stars
$18.76
-3.6%
N/A+74.0%$1.15B$700,000.000.00140
FNA
Paragon 28
1.5605 of 5 stars
$13.06
+0.3%
$14.20
+8.8%
+10.7%$1.09B$216.39M-17.64343,000Upcoming Earnings
Short Interest ↓
ESTA
Establishment Labs
2.0321 of 5 stars
$35.21
+5.3%
$60.60
+72.1%
-2.8%$985.88M$165.15M-13.65960Earnings Report

Related Companies and Tools


This page (NASDAQ:CVRX) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners